Prognostic Risk Models for the Development of Cardiovascular Dysfunction in Adolescents with Essential Hypertension


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We present prognostic risk models for structural and functional cardiovascular disorders in Caucasian adolescents (Russians) with essential hypertension aged 14-17 years (15.92±1.12) taking into account biochemical (catecholamines and cortisol) and genetic parameters (carriage of polymorphic variants of α2A-adrenergic receptor gene ARA2A (-1291С>G), norepinephrine transporter NET (-1287G>A), and D2-dopamine receptor DRD2 (-141C Ins/Del) and the data of psychological testing. Prognostically significant risk factors for increased specific peripheral vascular resistance and variability of daytime systolic BP were a combination of [CC+AA] genotypes of ADRA2A -1291C>G and NET -1287G>A polymorphisms, cortisol level, anxiety, and proneness to conflict. The combination of genotypes [CC+GG+II] of polymorphisms -1291C>G ADRA2A, -1287G>A NET and -141C Ins/Del DRD is prognostically significant, with the GG genotype NET being epistatic.

About the authors

A. S. Kosovtseva

Research Center for Family Health and Human Reproduction Problems

Author for correspondence.
Email: arjuna6402@rambler.ru
Russian Federation, Irkutsk

Т. А. Bairova

Research Center for Family Health and Human Reproduction Problems

Email: arjuna6402@rambler.ru
Russian Federation, Irkutsk

L. V. Rychkova

Research Center for Family Health and Human Reproduction Problems

Email: arjuna6402@rambler.ru
Russian Federation, Irkutsk

V. M. Polyakov

Research Center for Family Health and Human Reproduction Problems

Email: arjuna6402@rambler.ru
Russian Federation, Irkutsk

L. I. Kolesnikova

Research Center for Family Health and Human Reproduction Problems

Email: arjuna6402@rambler.ru
Russian Federation, Irkutsk


Copyright (c) 2019 Springer Science+Business Media, LLC, part of Springer Nature

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies